ArticleEndocrinology, diabetes & metabolism2022

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.

Jinghong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.